Symbiotics SICAV II - Emerging Impact Bond Fund A EUR Fonds
|
|
ISIN: LU2320788123
Anlageziel
The main objective of the Sub-Fund is to provide a Money Market Plus risk/return profile to investors resulting from economic value creation at the base of the pyramid mostly in EFMs. In particular, the objective of the Sub-Fund is to make sustainable investment within the meaning of article 9 of SFDR by focusing on businesses and projects which target LMIHs as well as MSMEs populations, with a view to fostering inclusive development impact for its clientele and long term value creation through sustainable principles (environment, social, governance) for its investors.
Stammdaten
| WKN | |
| ISIN | LU2320788123 |
| Fondsgesellschaft | Symbiotics |
| Kategorie | Anleihen Sonstige |
| Währung | EUR |
| Mindestanlage | |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager |
Aktuelle Daten
| Fondsnote | - |
| Aktueller Rücknahmepreis | 1 053,39 |
| Fonds Volumen | |
| Total Expense Ratio (TER) | 1,07 |
Gebühren
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| Rücknahmegebühr | % |
| Ausgabeaufschlag | % |
Basisdaten
| Auflagedatum | 09.04.2021 |
| Depotbank | CACEIS Bank, Luxembourg Branch |
| Zahlstelle | |
| Domizil | Luxembourg |
| Geschäftsjahr | 31.03.2025 |
Performancedaten
| Veränderung Vortag |